DR. ULENAERS MARIJKE – GASTRO-ENTEROLOGIE
0628.674.024 · rovalta.com · 28/09/2026
DR. ULENAERS MARIJKE – GASTRO-ENTEROLOGIE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODR. ULENAERS MARIJKE – GASTRO-ENTEROLOGIE is a Private limited company incorporated in 2015. Its registered office is in Stekene.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0628.674.024
- Incorporation
- 17/04/2015
- Legal form
- Private limited company
- Registered office
- Korte Dweersstraat(STE) 7
9190 Stekene · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 11 filingsTrend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 548,4 k € | +11.2% | 493,2 k € | +23.6% | 399 k € | +28.8% | 309,8 k € | +7.7% | 287,6 k € |
| EBITDA | 547,6 k € | +11.2% | 492,5 k € | +23.9% | 397,5 k € | +28.7% | 308,9 k € | +7.6% | 286,9 k € |
| Operating result | 512,9 k € | +16.8% | 439 k € | +22.0% | 359,8 k € | +36.9% | 262,7 k € | +9.7% | 239,6 k € |
| Net result | 385,7 k € | +18.0% | 327 k € | +20.0% | 272,5 k € | +38.2% | 197,2 k € | +10.5% | 178,5 k € |
| Balance sheet | |||||||||
| Equity | 347,8 k € | -11.2% | 391,7 k € | +17.8% | 332,6 k € | +79.3% | 185,6 k € | -6.7% | 199 k € |
| Total assets | 527,1 k € | -11.1% | 593,1 k € | +7.3% | 552,6 k € | +62.5% | 340 k € | -9.6% | 376,2 k € |
| Cash | 99,2 k € | -44.6% | 179,2 k € | +22.3% | 146,6 k € | +60.1% | 91,5 k € | -19.8% | 114,1 k € |
| Debts | 179,4 k € | -10.9% | 201,3 k € | -8.5% | 220 k € | +42.4% | 154,4 k € | -12.9% | 177,3 k € |
| Other | |||||||||
| Workforce | – | – | 0,0 ETP | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Marijke Ulenaers | Directorsince 17/04/2015Managerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 03/07/2025 | 14/07/2024 | 18/07/2023 | 12/07/2022 | 08/07/2021 |
| General meeting | 26/06/2026 | 27/06/2025 | 28/06/2024 | 30/06/2023 | 24/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 26/06/2026 | 30/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 27/06/2025 | 03/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 28/06/2024 | 14/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 18/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 24/06/2022 | 12/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 25/06/2021 | 08/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 26/06/2020 | 30/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 28/06/2019 | 26/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 29/06/2018 | 17/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 13/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 24/06/2016 | 10/08/2016 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Marijke Ulenaers | Directorsince 17/04/2015Managerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Korte Dweersstraat(STE) 7, 9190 StekeneCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00222679 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR. ULENAERS MARIJKE – GASTRO-ENTEROLOGIECurrent | accounts 2015 → 2025 | Accounts 2025 · 2026-00222679 |
Events
- 2025Annual accounts 2025385,7 k €↑
- 2024Annual accounts 2024327 k €↑
- 2023Annual accounts 2023272,5 k €↑
- 2022Annual accounts 2022197,2 k €↑
- 2021Annual accounts 2021178,5 k €↑
- 2019Annual accounts 201973,8 k €↑
- 2018Annual accounts 201838,8 k €↑
- 2017Annual accounts 201734,2 k €↓
- 2016Annual accounts 201646,7 k €↑
- 2015Annual accounts 201541,9 k €
- 17/04/2015IncorporationPrivate limited company